Joanna Archontaki

Commercialisation Executive

Joanna is a Commercialisation Executive working 50% in the Faculty of Natural Science and 50% in the Faculty of Medicine

Joanna's portfolio

A real-time fluorescence probe for Heme Oxygenase activity

A real-time fluorescence probe for Heme Oxygenase activity

Novel heme oxygenase 1 (HO-1) probe compositions, and methods covering easy-to-use and rapid readouts of cell protection in cardiovascular diseases, hemorrhage and red cell disorders. Find out more

The Benzodiazepine withdrawal symptom questionnaire (BWSQ)

The Benzodiazepine withdrawal symptom questionnaire (BWSQ)

BWSQ is the leading tool for assessing benzodiazepine withdrawal symptoms, used in a number of clinical trials involving benzodiazepines. Find out more

Aptamer-based multiplex screening platform

Aptamer-based multiplex screening platform

A fully flexible, scalable and low-cost detection platform to sense multiple protein targets simultaneously by grafting specific sequences along the backbone of a double-stranded DNA carrier. Find out more

Portfolio of human colorectal adenocarcinomas

Portfolio of human colorectal adenocarcinomas

A portfolio of human colorectal adenocarcenoma cell lines including primary cell lines isolated from patients (of various Duke's stages and histological grades) in addition to cloned cells lines genetically modified to highly express alpha integrin domains. Find out more

DEP Trapping Using Metallised Nanopipettes

DEP Trapping Using Metallised Nanopipettes

This invention enables efficient single molecule nanopore sensing at femtomolar concentrations using dielectrophoretic trapping by combining nanopore sensing and dielectrophoresis (DEP). Find out more

Nanotweezers for single-cell biopsy

Nanotweezers for single-cell biopsy

Inexpensive, easy to fabricate and use, dielectrophoretic nanotweezers for non-destructive subcellular concentration (trapping) and extraction of biomolecules. Find out more

Charcot-Marie Tooth Disease model

Charcot-Marie Tooth Disease model

Proposed use Research into Charcot-Marie Tooth Disease (Type 1A). Research into autoimmune neurological disorders would be the main ... Find out more

MicroRNA Biomarkers for ectopic or intrauterine pregnancy

MicroRNA Biomarkers for ectopic or intrauterine pregnancy

MicroRNA are important gene regulators and their expression profiles change with pathophysiology, allowing their use as biomarkers. Imperial researchers have identified differential markers that can distinguish pregnancy of unknown location (PUL). Find out more

Management of pre-term labour via an application for pathway selective EP2 agonist

Management of pre-term labour via an application for pathway selective EP2 agonist

An EP2 receptor agonist with an application as a novel tocolytic for the management of pre-term labour. Find out more

Complement Factor H Knock Out Mouse Model

Complement Factor H Knock Out Mouse Model

In the field of eye disease, such as age-related macular degeneration (AMD) this mouse model has been proven important for research into the mechanisms of disease. This disease model is useful for conditions in which complement factor H plays a role. Find out more

MicroRNA plasma markers for small-for-gestational-age (SGA) births

MicroRNA plasma markers for small-for-gestational-age (SGA) births

Markers to determine the risk of SGA births based on miRNA plasma detected from maternal blood samples. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...